Kestra Private Wealth Services LLC Buys New Shares in iShares U.S. Pharmaceuticals ETF $IHE

Kestra Private Wealth Services LLC bought a new position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) in the third quarter, Holdings Channel reports. The fund bought 5,312 shares of the company’s stock, valued at approximately $534,000.

A number of other large investors have also recently added to or reduced their stakes in the business. Sunbelt Securities Inc. grew its position in iShares U.S. Pharmaceuticals ETF by 14.3% in the first quarter. Sunbelt Securities Inc. now owns 960 shares of the company’s stock worth $83,000 after buying an additional 120 shares during the last quarter. Balance Wealth Partners LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 3rd quarter valued at $42,000. NewEdge Advisors LLC lifted its position in shares of iShares U.S. Pharmaceuticals ETF by 45.1% during the 1st quarter. NewEdge Advisors LLC now owns 1,397 shares of the company’s stock valued at $121,000 after acquiring an additional 434 shares during the last quarter. Root Financial Partners LLC bought a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 3rd quarter worth $51,000. Finally, Kestra Advisory Services LLC boosted its stake in shares of iShares U.S. Pharmaceuticals ETF by 10.0% during the 1st quarter. Kestra Advisory Services LLC now owns 6,303 shares of the company’s stock worth $546,000 after acquiring an additional 571 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Stock Up 1.0%

Shares of NYSEARCA IHE opened at $106.60 on Friday. The stock has a market capitalization of $1.61 billion, a price-to-earnings ratio of 17.75 and a beta of 0.47. The stock’s fifty day simple moving average is $102.48 and its 200 day simple moving average is $95.27. iShares U.S. Pharmaceuticals ETF has a 52-week low of $75.03 and a 52-week high of $110.44.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.